{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ahmad AM"],"funding":["World Health Organization","Health Services Academy, Islamabad, Pakistan"],"pagination":["e055381"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8987211"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(4)"],"pubmed_abstract":["<h4>Objectives</h4>This study adapted WHO's <b>'</b>Unity Study' protocol to estimate the population prevalence of antibodies to SARS CoV-2 and risk factors for developing SARS-CoV-2 infection.<h4>Design</h4>This population-based, age-stratified cross-sectional study was conducted at the level of households (HH).<h4>Participants</h4>All ages and genders were eligible for the study (exclusion criteria: contraindications to venipuncture- however, no such case was encountered). 4998 HH out of 6599 consented (1 individual per HH). The proportion of male and female study participants was similar.<h4>Primary and secondary outcome measures</h4>Following were the measured outcome measures- these were different from the planned indicators (i.e. two out of the three planned indicators were measured)"],"journal":["BMJ open"],"pubmed_title":["COVID-19 seroprevalence in Pakistan: a cross-sectional study."],"pmcid":["PMC8987211"],"funding_grant_id":["F-11-2020-WHO/DAi/HSA"],"pubmed_authors":["Hafeez A","Masood M","Ahmad AM","Abbasi F","Shahzad K","Umar M"],"additional_accession":[]},"is_claimable":false,"name":"COVID-19 seroprevalence in Pakistan: a cross-sectional study.","description":"<h4>Objectives</h4>This study adapted WHO's <b>'</b>Unity Study' protocol to estimate the population prevalence of antibodies to SARS CoV-2 and risk factors for developing SARS-CoV-2 infection.<h4>Design</h4>This population-based, age-stratified cross-sectional study was conducted at the level of households (HH).<h4>Participants</h4>All ages and genders were eligible for the study (exclusion criteria: contraindications to venipuncture- however, no such case was encountered). 4998 HH out of 6599 consented (1 individual per HH). The proportion of male and female study participants was similar.<h4>Primary and secondary outcome measures</h4>Following were the measured outcome measures- these were different from the planned indicators (i.e. two out of the three planned indicators were measured)","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-04T12:57:43.872Z","creation":"2025-04-04T12:57:43.872Z"},"accession":"S-EPMC8987211","cross_references":{"pubmed":["35387815"],"doi":["10.1136/bmjopen-2021-055381"]}}